Top Markets
Coin of the day
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Classificação em ações #24454
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Preço da ação
$0.78611575
Valor de mercado
$60.45M
Variação (1 dia)
0.00%
Variação (1 ano)
-12.06%
País
NO
Negociar Lytix Biopharma AS (LYTIX)

Categoria

Preço LYTIX com a capitalização de mercado de B
Lytix Biopharma AS Lytix Biopharma AS
LYTIX
$0.78611575
Capitalização de mercado de Lytix Biopharma AS(LYTIX)
Valor de mercado: $60.45M
Em August 2026, Lytix Biopharma AS tem uma capitalização de mercado de $60.45M. Isso faz com que Lytix Biopharma AS seja a 24454th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Lytix Biopharma AS de 2021 a 2026
LYTIX comparado com o topo de 5 mais populares stocks
Preço para LYTIX Ativo B Capitalização de mercado de B Resultados
Lytix Biopharma AS Lytix Biopharma AS
$67,891.24 $60.45M
$5.221T +8,636,190.89%
Lytix Biopharma AS Lytix Biopharma AS
$59,390.21 $60.45M
$4.567T +7,554,793.23%
Lytix Biopharma AS Lytix Biopharma AS
$54,128.67 $60.45M
$4.162T +6,885,484.73%
Lytix Biopharma AS Lytix Biopharma AS
$46,789.66 $60.45M
$3.598T +5,951,905.89%
Lytix Biopharma AS Lytix Biopharma AS
$36,176.17 $60.45M
$2.782T +4,601,788.39%